GalNAc-conjugated siRNA therapeutic (Mitotherapeutix)

N/A

Report date: 2025/03/20 15:49:38
NME

Base Information

Drug NameGalNAc-conjugated siRNA therapeutic (Mitotherapeutix)
Drug Alias NamesiMCJ (Mitotherapeutix)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHepatic InsufficiencyMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMitotherapeutix LLC
China Registration ClassN/A

Develop Information

Active CompaniesMitotherapeutix LLC
Inactive CompaniesN/A
Active IndicationsHepatic InsufficiencyMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A